Literature DB >> 7629380

Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.

M A Pierotti1, I Bongarzone, M G Borrello, C Mariani, C Miranda, G Sozzi, A Greco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629380     DOI： 10.1007/BF03349721

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  17 in total

1.  The human tpr gene encodes a protein of 2094 amino acids that has extensive coiled-coil regions and an acidic C-terminal domain.

Authors:  P J Mitchell; C S Cooper
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

2.  Mechanism of met oncogene activation.

Authors:  M Park; M Dean; C S Cooper; M Schmidt; S J O'Brien; D G Blair; G F Vande Woude
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

3.  A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.

Authors:  D Martin-Zanca; S H Hughes; M Barbacid
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

4.  Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.

Authors:  M Park; M Dean; K Kaul; M J Braun; M A Gonda; G Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Human TRK proto-oncogene maps to chromosome 1q32-q41.

Authors:  M Miozzo; M A Pierotti; G Sozzi; P Radice; I Bongarzone; N K Spurr; G Della Porta
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

6.  High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.

Authors:  I Bongarzone; M A Pierotti; N Monzini; P Mondellini; G Manenti; R Donghi; S Pilotti; M Grieco; M Santoro; A Fusco
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

7.  Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas.

Authors:  G Sozzi; I Bongarzone; M Miozzo; C T Cariani; P Mondellini; C Calderone; S Pilotti; M A Pierotti; G Della Porta
Journal:  Genes Chromosomes Cancer       Date:  1992-10       Impact factor: 5.006

8.  TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.

Authors:  A Greco; M A Pierotti; I Bongarzone; S Pagliardini; C Lanzi; G Della Porta
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

9.  Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.

Authors:  A Greco; C Mariani; C Miranda; S Pagliardini; M A Pierotti
Journal:  Genomics       Date:  1993-11       Impact factor: 5.736

10.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

Authors:  L Naldini; E Vigna; R P Narsimhan; G Gaudino; R Zarnegar; G K Michalopoulos; P M Comoglio
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867
View more
  19 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

2.  AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.

Authors:  Radhika Iyer; Carly R Varela; Jane E Minturn; Ruth Ho; Anisha M Simpson; Jennifer E Light; Audrey E Evans; Huaqing Zhao; Kenneth Thress; Jeffrey L Brown; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-24       Impact factor: 3.333

3.  ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

Authors:  G W Colleoni; J A Bridge; B Garicochea; J Liu; D A Filippa; M Ladanyi
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 4.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

5.  Low frequency of rearrangement of TRK protooncogene in Chinese thyroid tumors.

Authors:  C S Kuo; C Y Lin; C W Hsu; C H Lee; H D Lin
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

6.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

Review 7.  Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.

Authors:  Manoj Gandhi; Viktoria Evdokimova; Yuri E Nikiforov
Journal:  Mol Cell Endocrinol       Date:  2009-09-18       Impact factor: 4.102

8.  Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.

Authors:  A H Fischer; J A Bond; P Taysavang; O E Battles; D Wynford-Thomas
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis.

Authors:  Lucas Goedert; Jessica Rodrigues Plaça; Cesar Seigi Fuziwara; Maiaro Cabral Rosa Machado; Desirée Rodrigues Plaça; Palloma Porto Almeida; Talita Perez Sanches; Jair Figueredo Dos Santos; Amanda Cristina Corveloni; Illy Enne Gomes Pereira; Marcela Motta de Castro; Edna Teruko Kimura; Wilson Araújo Silva; Enilza Maria Espreafico
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

10.  UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.

Authors:  P Pallante; M T Berlingieri; G Troncone; M Kruhoffer; T F Orntoft; G Viglietto; A Caleo; I Migliaccio; M Decaussin-Petrucci; M Santoro; L Palombini; A Fusco
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.